These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32753585)

  • 1. Human antimicrobial peptide, LL-37, induces non-inheritable reduced susceptibility to vancomycin in Staphylococcus aureus.
    Friberg C; Haaber JK; Vestergaard M; Fait A; Perrot V; Levin BR; Ingmer H
    Sci Rep; 2020 Aug; 10(1):13121. PubMed ID: 32753585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus.
    Shurko JF; Galega RS; Li C; Lee GC
    J Antibiot (Tokyo); 2018 Nov; 71(11):971-974. PubMed ID: 30120393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37.
    Le J; Dam Q; Schweizer M; Thienphrapa W; Nizet V; Sakoulas G
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1441-7. PubMed ID: 27234592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus.
    Ouhara K; Komatsuzawa H; Kawai T; Nishi H; Fujiwara T; Fujiue Y; Kuwabara M; Sayama K; Hashimoto K; Sugai M
    J Antimicrob Chemother; 2008 Jun; 61(6):1266-9. PubMed ID: 18367458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus.
    Singh NB; Yim J; Jahanbakhsh S; Sakoulas G; Rybak MJ
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):363-370. PubMed ID: 29807674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Small-Molecule Inhibitor of
    Huang Y; Alumasa JN; Callaghan LT; Baugh RS; Rae CD; Keiler KC; McGillivray SM
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917982
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus aureus.
    Koppen BC; Mulder PPG; de Boer L; Riool M; Drijfhout JW; Zaat SAJ
    Int J Antimicrob Agents; 2019 Feb; 53(2):143-151. PubMed ID: 30315918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants.
    Zhang P; Wright JA; Tymon A; Nair SP
    J Antimicrob Chemother; 2018 Mar; 73(3):615-619. PubMed ID: 29211886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic epidermicin NI01 can protect Galleria mellonella larvae from infection with Staphylococcus aureus.
    Gibreel TM; Upton M
    J Antimicrob Chemother; 2013 Oct; 68(10):2269-73. PubMed ID: 23711896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus at an Indian tertiary hospital: Antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents.
    Khurana S; Mathur P; Malhotra R
    J Glob Antimicrob Resist; 2019 Jun; 17():98-102. PubMed ID: 30389637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antimicrobial peptide LL-37 for treatment of Staphylococcus aureus biofilm on titanium plate.
    Wei J; Cao X; Qian J; Liu Z; Wang X; Su Q; Wang Y; Xie R; Li X
    Medicine (Baltimore); 2021 Nov; 100(44):e27426. PubMed ID: 34871207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model.
    Narayana JL; Mishra B; Lushnikova T; Golla RM; Wang G
    Biochim Biophys Acta Biomembr; 2019 Sep; 1861(9):1592-1602. PubMed ID: 31319057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of reduced vancomycin susceptibility of MRSA strain Mu50 with various conditions of antibiotic susceptibility tests].
    Hanaki H; Hiramatsu K
    Jpn J Antibiot; 1997 Sep; 50(9):794-8. PubMed ID: 9394239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA).
    Ciandrini E; Morroni G; Arzeni D; Kamysz W; Neubauer D; Kamysz E; Cirioni O; Brescini L; Baffone W; Campana R
    Curr Top Med Chem; 2018; 18(24):2116-2126. PubMed ID: 30345920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.
    Midorikawa K; Ouhara K; Komatsuzawa H; Kawai T; Yamada S; Fujiwara T; Yamazaki K; Sayama K; Taubman MA; Kurihara H; Hashimoto K; Sugai M
    Infect Immun; 2003 Jul; 71(7):3730-9. PubMed ID: 12819054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
    Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D
    BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.